{"entity":{"type":"insider","cik":"0001741553","url":"/insider/0001741553","json_url":"/insider/0001741553.json","name":"Duncan Jason","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":17,"first":"2020-01-23","last":"2023-01-23","span_basis":"filed_date"},"name_variants":[{"name":"Duncan Jason","source":"filing","n_filings":17,"first_seen":"2020-01-23","last_seen":"2023-01-23"}],"transactions":[{"id":7948838,"accession":"0001209191-23-004451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004451","line_url":"/filing/0001209191-23-004451#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":228.0,"shares_display":"228","price_per_share":43.8,"price_display":"43.80","price_state":"stated","total_value":9986.4,"total_display":"9,986.40","total_whole":"9,986","shares_owned_after":14146.0,"shares_owned_after_display":"14,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-23","filed_date":"2023-01-23","scope":"insider"},{"id":8324741,"accession":"0001209191-23-004223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004223","line_url":"/filing/0001209191-23-004223#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":938.0,"shares_display":"938","price_per_share":43.9044,"price_display":"43.90","price_state":"stated","total_value":41182.3272,"total_display":"41,182.33","total_whole":"41,182","shares_owned_after":14374.0,"shares_owned_after_display":"14,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-20","scope":"insider"},{"id":6150012,"accession":"0001209191-22-054490","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-054490","line_url":"/filing/0001209191-22-054490","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":656.0,"shares_display":"656","price_per_share":19.445530487804877,"price_display":"19.45","price_state":"stated","total_value":12756.268,"total_display":"12,756.27","total_whole":"12,756","shares_owned_after":14931.0,"shares_owned_after_display":"14,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-25","scope":"insider","n_lines":3},{"id":6185278,"accession":"0001209191-22-043100","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-043100","line_url":"/filing/0001209191-22-043100","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":313.0,"shares_display":"313","price_per_share":23.875223642172525,"price_display":"23.88","price_state":"stated","total_value":7472.945,"total_display":"7,472.94","total_whole":"7,473","shares_owned_after":15587.0,"shares_owned_after_display":"15,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-25","scope":"insider","n_lines":2},{"id":6185272,"accession":"0001209191-22-043100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-043100","line_url":"/filing/0001209191-22-043100","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":344.0,"shares_display":"344","price_per_share":24.52004011627907,"price_display":"24.52","price_state":"stated","total_value":8434.8938,"total_display":"8,434.89","total_whole":"8,435","shares_owned_after":15900.0,"shares_owned_after_display":"15,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-22","filed_date":"2022-07-25","scope":"insider","n_lines":2},{"id":6546566,"accession":"0001209191-22-025522","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-22-025522","line_url":"/filing/0001209191-22-025522","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":312.0,"shares_display":"312","price_per_share":33.42815,"price_display":"33.43","price_state":"stated","total_value":10429.5828,"total_display":"10,429.58","total_whole":"10,430","shares_owned_after":16099.0,"shares_owned_after_display":"16,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-25","filed_date":"2022-04-25","scope":"insider","n_lines":2},{"id":6546560,"accession":"0001209191-22-025522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-025522","line_url":"/filing/0001209191-22-025522","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":343.0,"shares_display":"343","price_per_share":33.026667930029156,"price_display":"33.03","price_state":"stated","total_value":11328.1471,"total_display":"11,328.15","total_whole":"11,328","shares_owned_after":16423.0,"shares_owned_after_display":"16,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-25","scope":"insider","n_lines":2},{"id":6446767,"accession":"0001209191-22-004809","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-004809","line_url":"/filing/0001209191-22-004809","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1688.0,"shares_display":"1,688","price_per_share":24.93722511848341,"price_display":"24.94","price_state":"stated","total_value":42094.036,"total_display":"42,094.04","total_whole":"42,094","shares_owned_after":16663.0,"shares_owned_after_display":"16,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider","n_lines":3},{"id":4147905,"accession":"0001209191-21-061556","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-061556","line_url":"/filing/0001209191-21-061556#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":217.0,"shares_display":"217","price_per_share":29.21,"price_display":"29.21","price_state":"stated","total_value":6338.57,"total_display":"6,338.57","total_whole":"6,339","shares_owned_after":7355.0,"shares_owned_after_display":"7,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-25","filed_date":"2021-10-25","scope":"insider"},{"id":4147902,"accession":"0001209191-21-061556","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-061556","line_url":"/filing/0001209191-21-061556#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":95.0,"shares_display":"95","price_per_share":28.8508,"price_display":"28.85","price_state":"stated","total_value":2740.826,"total_display":"2,740.83","total_whole":"2,741","shares_owned_after":7572.0,"shares_owned_after_display":"7,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-25","scope":"insider"},{"id":4485236,"accession":"0001209191-21-048160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-048160","line_url":"/filing/0001209191-21-048160#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223.0,"shares_display":"223","price_per_share":31.43,"price_display":"31.43","price_state":"stated","total_value":7008.89,"total_display":"7,008.89","total_whole":"7,009","shares_owned_after":7667.0,"shares_owned_after_display":"7,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-26","scope":"insider"},{"id":4485230,"accession":"0001209191-21-048160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-048160","line_url":"/filing/0001209191-21-048160#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90.0,"shares_display":"90","price_per_share":34.13,"price_display":"34.13","price_state":"stated","total_value":3071.7,"total_display":"3,071.70","total_whole":"3,072","shares_owned_after":7890.0,"shares_owned_after_display":"7,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-26","scope":"insider"},{"id":4484535,"accession":"0001209191-21-043467","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-043467","line_url":"/filing/0001209191-21-043467#line-5","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6300.0,"shares_display":"6,300","price_per_share":36.22,"price_display":"36.22","price_state":"stated","total_value":228186.0,"total_display":"228,186.00","total_whole":"228,186","shares_owned_after":7980.0,"shares_owned_after_display":"7,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-28","scope":"insider"},{"id":4484522,"accession":"0001209191-21-043467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-043467","line_url":"/filing/0001209191-21-043467#line-3","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":36.38,"price_display":"36.38","price_state":"stated","total_value":363800.0,"total_display":"363,800.00","total_whole":"363,800","shares_owned_after":7980.0,"shares_owned_after_display":"7,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-28","scope":"insider"},{"id":5475384,"accession":"0001209191-21-028384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-028384","line_url":"/filing/0001209191-21-028384#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":222.0,"shares_display":"222","price_per_share":32.32,"price_display":"32.32","price_state":"stated","total_value":7175.04,"total_display":"7,175.04","total_whole":"7,175","shares_owned_after":7849.0,"shares_owned_after_display":"7,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-26","scope":"insider"},{"id":5475379,"accession":"0001209191-21-028384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-028384","line_url":"/filing/0001209191-21-028384#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90.0,"shares_display":"90","price_per_share":31.75,"price_display":"31.75","price_state":"stated","total_value":2857.5,"total_display":"2,857.50","total_whole":"2,858","shares_owned_after":8071.0,"shares_owned_after_display":"8,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-22","filed_date":"2021-04-26","scope":"insider"},{"id":5291004,"accession":"0001209191-21-024891","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-024891","line_url":"/filing/0001209191-21-024891#line-3","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":36.1567,"price_display":"36.16","price_state":"stated","total_value":10847.01,"total_display":"10,847.01","total_whole":"10,847","shares_owned_after":8161.0,"shares_owned_after_display":"8,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-04-02","scope":"insider"},{"id":5290990,"accession":"0001209191-21-024891","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-024891","line_url":"/filing/0001209191-21-024891#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1426.0,"shares_display":"1,426","price_per_share":35.0417,"price_display":"35.04","price_state":"stated","total_value":49969.4642,"total_display":"49,969.46","total_whole":"49,969","shares_owned_after":8161.0,"shares_owned_after_display":"8,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-04-02","scope":"insider"},{"id":5034600,"accession":"0001209191-21-005162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-005162","line_url":"/filing/0001209191-21-005162#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":110.0,"shares_display":"110","price_per_share":34.62,"price_display":"34.62","price_state":"stated","total_value":3808.2,"total_display":"3,808.20","total_whole":"3,808","shares_owned_after":9332.0,"shares_owned_after_display":"9,332","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-22","filed_date":"2021-01-25","scope":"insider"},{"id":2225146,"accession":"0001209191-20-055674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055674","line_url":"/filing/0001209191-20-055674#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89.0,"shares_display":"89","price_per_share":34.71,"price_display":"34.71","price_state":"stated","total_value":3089.19,"total_display":"3,089.19","total_whole":"3,089","shares_owned_after":3781.0,"shares_owned_after_display":"3,781","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-22","filed_date":"2020-10-23","scope":"insider"},{"id":2248316,"accession":"0001209191-20-050081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-050081","line_url":"/filing/0001209191-20-050081#line-2","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":45.55,"price_display":"45.55","price_state":"stated","total_value":182200.0,"total_display":"182,200.00","total_whole":"182,200","shares_owned_after":3870.0,"shares_owned_after_display":"3,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2437316,"accession":"0001209191-20-043475","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-043475","line_url":"/filing/0001209191-20-043475#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91.0,"shares_display":"91","price_per_share":25.8,"price_display":"25.80","price_state":"stated","total_value":2347.8,"total_display":"2,347.80","total_whole":"2,348","shares_owned_after":4370.0,"shares_owned_after_display":"4,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-22","filed_date":"2020-07-23","scope":"insider"},{"id":2435664,"accession":"0001209191-20-025642","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-025642","line_url":"/filing/0001209191-20-025642#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":17.68,"price_display":"17.68","price_state":"stated","total_value":1626.56,"total_display":"1,626.56","total_whole":"1,627","shares_owned_after":4461.0,"shares_owned_after_display":"4,461","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-22","filed_date":"2020-04-24","scope":"insider"},{"id":2528802,"accession":"0001209191-20-004740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-004740","line_url":"/filing/0001209191-20-004740#line-1","is_derivative":false,"issuer_cik":"0001322505","issuer_name":"ALBIREO PHARMA, INC.","issuer_ticker":"ALBO","issuer_name_source":null,"issuer_url":"/issuer/0001322505","owner_cik":"0001741553","owner_name":"Duncan Jason","owner_display_name":"Duncan Jason","owner_url":"/insider/0001741553","role":"Officer (Chief Legal Officer and GC)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer and GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer and GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":447.0,"shares_display":"447","price_per_share":23.97,"price_display":"23.97","price_state":"stated","total_value":10714.59,"total_display":"10,714.59","total_whole":"10,715","shares_owned_after":4553.0,"shares_owned_after_display":"4,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-22","filed_date":"2020-01-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001322505","name":"ALBIREO PHARMA, INC.","url":"/issuer/0001322505","role":"Officer (Chief Legal Officer and GC)","n_filings":17,"first_seen":"2020-01-23","last_seen":"2023-01-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001741553","retrieved_at":"2026-08-23T09:20:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}